Triangle biotech startup focusing on depression disorder raises $45M

Arrivo BioVentures, which emerged from stealth mode less than two years ago with $49 million in funding and four drug candidates, has raised another $45 million and plans to advance its treatment focused on major depression disorder or MDD.

Related Keywords

,Rex Health Ventures ,Solas Bioventures Emerging Healthcare Fund ,Orlando Health Ventures ,Arrivo Bioventures ,Triangle Based Rex Health ,Steve Butts ,